Skip to main content
. 2021 May 25;50(5):654–659. doi: 10.1016/j.hrtlng.2021.04.008

Table 3.

Laboratory markers and radiological findings,.Data are presented as n (%)or median (IQR).

Total (n = 32) non-survivor (n = 24) survivor (n = 8) p value
Laboratory Markers
White Bloodcell Count (x10^9/L) 7.0 (5.2–10.7) 7.6 (6.2–10.9) 5.2 (5.0–6.3) 0.04
absolute lymfocyt count (x10^9/l) 1.0 (0.7–1.4) 0.9 (0.6–1.4) 1.1 (1.0–1.4) 0.27
hemoglobin (mmol/l) 8.1 (7.4–8.9) 8.1 (7.0–8.9) 8.5 (8.0–9.2) 0.27
Platelet Count (x10^9/L) 211 (180–281) 207 (182–279) 242 (182–335) 0.60
Alanine aminotransferase (U/L) 31 (25–40) 30 (25–39) 34 (29–40) 0.36
Aspartate aminotransferase (U/L) 59 (45–68) 54 (39–68) 60 (59–67) 0.28
Lactate dehydrogenase(U/L) 409 (296–528) 391 (280–581) 424 (395–517) 0.56
D-Dimer (mg/L) 1.4 (1.0–3.7) 1.34 (1.0–3.7) 1.3 (1.0–2.3) 0.77
Procalcitonin (µg/L) 0.17 (0.12–0.36) 0.22 (0.16–0.51) 0.12 (0.1–0.16) 0.03
Ferritin (µg/L) 695 (373–1313) 884 (397–1438) 498 (386–794) 0.32
C-reactive protein (mg/L) 111 (67–141) 111 (66–141) 119 (76–146) 0.84
Radiological findings
Chest X-Ray Bilateral Pulmonary Infiltration 23 (72%) 16 (67%) 7 (88%) 0.39
Unilateral Pulmonary Infiltration 5 (16%) 5 (21%) 0 (0%) 0.30
No Pulmonary Infiltration 4 (12%) 3 (12%) 1 (12%) 1.00
Computed Tomography scan 12 (38%) 8 (33%) 4 (50%) 0.43
Pulmonary embolism 5 (45%) 4 (57%) 1 (25%) 0.55